Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?

We have checked the vaccination history of 389 elderly patients (62.9% males, mean age of 78.5 + 8.4 years) hospitalized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Information regarding pneumococcal vaccination was available for 354 patients (91.0%): the overall vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sticchi, Laura, Taramasso, Lucia, Di Biagio, Antonio, Olobardi, Dario, Icardi, Giancarlo, Bassetti, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115564/
https://www.ncbi.nlm.nih.gov/pubmed/33180669
http://dx.doi.org/10.1080/21645515.2020.1829413
_version_ 1783691228337930240
author Sticchi, Laura
Taramasso, Lucia
Di Biagio, Antonio
Olobardi, Dario
Icardi, Giancarlo
Bassetti, Matteo
author_facet Sticchi, Laura
Taramasso, Lucia
Di Biagio, Antonio
Olobardi, Dario
Icardi, Giancarlo
Bassetti, Matteo
author_sort Sticchi, Laura
collection PubMed
description We have checked the vaccination history of 389 elderly patients (62.9% males, mean age of 78.5 + 8.4 years) hospitalized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Information regarding pneumococcal vaccination was available for 354 patients (91.0%): the overall vaccination coverage rate (VCR) was 19.8% (70/354), 11.3% received only 13-valent pneumococcal conjugate vaccine (PCV13), 3.4% were immunized with 23-valent pneumococcal polysaccharide vaccine (PPSV23), 5.1% received both vaccines. VCR among the elderly population in Liguria Region was 26.2% (118,581/453,082), among them 13.7% received PCV13, 12.4% were immunized with at least one dose of PPSV23. Regarding the 2019–2020 influenza season vaccination data were available for 46 patients: 59% of them were immunized. VCR in the elderly population was 51.7% (234,153/453,082).
format Online
Article
Text
id pubmed-8115564
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-81155642021-05-17 Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave? Sticchi, Laura Taramasso, Lucia Di Biagio, Antonio Olobardi, Dario Icardi, Giancarlo Bassetti, Matteo Hum Vaccin Immunother Letter We have checked the vaccination history of 389 elderly patients (62.9% males, mean age of 78.5 + 8.4 years) hospitalized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Information regarding pneumococcal vaccination was available for 354 patients (91.0%): the overall vaccination coverage rate (VCR) was 19.8% (70/354), 11.3% received only 13-valent pneumococcal conjugate vaccine (PCV13), 3.4% were immunized with 23-valent pneumococcal polysaccharide vaccine (PPSV23), 5.1% received both vaccines. VCR among the elderly population in Liguria Region was 26.2% (118,581/453,082), among them 13.7% received PCV13, 12.4% were immunized with at least one dose of PPSV23. Regarding the 2019–2020 influenza season vaccination data were available for 46 patients: 59% of them were immunized. VCR in the elderly population was 51.7% (234,153/453,082). Taylor & Francis 2020-11-12 /pmc/articles/PMC8115564/ /pubmed/33180669 http://dx.doi.org/10.1080/21645515.2020.1829413 Text en © 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Letter
Sticchi, Laura
Taramasso, Lucia
Di Biagio, Antonio
Olobardi, Dario
Icardi, Giancarlo
Bassetti, Matteo
Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?
title Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?
title_full Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?
title_fullStr Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?
title_full_unstemmed Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?
title_short Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?
title_sort will vaccine hesitancy compromise our efforts to face the next sars-cov-2 epidemic wave?
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115564/
https://www.ncbi.nlm.nih.gov/pubmed/33180669
http://dx.doi.org/10.1080/21645515.2020.1829413
work_keys_str_mv AT sticchilaura willvaccinehesitancycompromiseoureffortstofacethenextsarscov2epidemicwave
AT taramassolucia willvaccinehesitancycompromiseoureffortstofacethenextsarscov2epidemicwave
AT dibiagioantonio willvaccinehesitancycompromiseoureffortstofacethenextsarscov2epidemicwave
AT olobardidario willvaccinehesitancycompromiseoureffortstofacethenextsarscov2epidemicwave
AT icardigiancarlo willvaccinehesitancycompromiseoureffortstofacethenextsarscov2epidemicwave
AT bassettimatteo willvaccinehesitancycompromiseoureffortstofacethenextsarscov2epidemicwave

Ejemplares similares